Surfactant-dependence of nanoparticle treatment in murine experimental colitis

Journal of Controlled Release

Volumn 172, Issue 1, 2013, Pages 62-68

  Wachsmann, Philip ^a   Moulari, Brice ^b   Béduneau, Arnaud ^b   Pellequer, Yann ^b   Lamprecht, Alf ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Experimental colitis; Inflammatory bowel disease; Nanoparticles; Surface properties; Surfactants

Indexed keywords

ANTI-INFLAMMATORIES; CETYL TRIMETHYL AMMONIUM BROMIDES; DRUG CARRIER SYSTEMS; EMULSIFICATION-SOLVENT EVAPORATIONS; EXPERIMENTAL COLITIS; INFLAMMATORY BOWEL DISEASE; SODIUM DODECYL SULPHATE; THERAPEUTIC EFFICIENCY;

EMULSIFICATION; EMULSIONS; NANOPARTICLES; SODIUM; SURFACE ACTIVE AGENTS; SURFACE PROPERTIES;

DISEASES;

BETAMETHASONE; CETRIMIDE; CHOLIC ACID; DODECYL SULFATE SODIUM; NANOPARTICLE; POLYSORBATE 20; POLYVINYL ALCOHOL; SODIUM CHLORIDE; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; ENCAPSULATION; EVAPORATION; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL;

EXPERIMENTAL COLITIS; INFLAMMATORY BOWEL DISEASE; NANOPARTICLES; SURFACE PROPERTIES; SURFACTANTS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; CELL LINE; COLITIS; DRUG CARRIERS; INFLAMMATORY BOWEL DISEASES; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; SURFACE-ACTIVE AGENTS;

EID: 84883521048     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.07.031     Document Type: Article

References (28)

1. R.B. Sartor Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis Nat. Clin. Pract. Gastroenterol. Hepatol. 3 2006 390 407 (Pubitemid 44018812)
2. P. Gionchetti, F. Rizzello, F. Habal, C. Morselli, C. Amadini, R. Romagnoli, and M. Campieri Standard treatment of ulcerative colitis Dig. Dis. 21 2003 157 167 (Pubitemid 37323494)
3. A. Lamprecht IBD: selective nanoparticle adhesion can enhance colitis therapy Nat. Rev. Gastroenterol. Hepatol. 7 2010 311 312
4. A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats J. Pharmacol. Exp. Ther. 315 2005 196 202 (Pubitemid 41380512)
5. A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles J. Control. Release 104 2005 337 346 (Pubitemid 40724934)
6. D. Pertuit, B. Moulari, T. Betz, A. Nadaradjane, D. Neumann, L. Ismaïli, B. Refouvelet, Y. Pellequer, and A. Lamprecht 5-Amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease J. Control. Release 123 2007 211 218 (Pubitemid 350007824)
7. B. Moulari, D. Pertuit, Y. Pellequer, and A. Lamprecht The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis Biomaterials 29 2008 4554 4560
8. H. Laroui, G. Dalmasso, H.T. Nguyen, Y. Yan, S.V. Sitaraman, and D. Merlin Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model Gastroenterology 138 2010 843 853
9. M. Gaumet, R. Gurny, and F. Delie Localization and quantification of biodegradable particles in an intestinal cell model: the influence of particle size Eur. J. Pharm. Sci. 36 2009 465 473
10. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier, and J.M. DeSimone The effect of particle design on cellular internalization pathways PNAS 105 2008 11613 11618
11. K.Y. Win, and S.-S. Feng Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs Biomaterials 26 2005 2713 2722 (Pubitemid 39600724)
12. T.T. Jubeh, Y. Barenholz, and A. Rubinstein Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes Pharm. Res. 21 2004 447 453 (Pubitemid 38338980)
13. B. Tirosh, N. Khatib, Y. Barenholz, A. Nissan, and A. Rubinstein Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa Mol. Pharm. 6 2009 1083 1091
14. W. Niebel, K. Walkenbach, A. Béduneau, Y. Pellequer, and A. Lamprecht Nanoparticle-based clodronate delivery mitigates murine experimental colitis J. Control. Release 160 2012 659 665
15. C. Vauthier, and K. Bouchemal Methods for the preparation and manufacture of polymeric nanoparticles Pharm. Res. 26 2009 1025 1058
16. M.M.A. Abdel-Mottaleb, B. Moulari, A. Béduneau, Y. Pellequer, and A. Lamprecht Surface-charge-dependent nanoparticles accumulation in inflamed skin J. Pharm. Sci. 101 2012 4231 4239
17. A. Lamprecht, P. Koenig, N. Ubrich, P. Maincent, and D. Neumann Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells Nanotechnology 17 2006 3673 3680 (Pubitemid 44424393)
18. J.E. Krawisz, P. Sharon, and W.F. Stenson Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models Gastroenterology 87 1984 1344 1350 (Pubitemid 15201434)
19. S. Hassani, Y. Pellequer, and A. Lamprecht Selective adhesion of nanoparticles to inflamed tissue in gastric ulcers Pharm. Res. 26 2009 1149 1154
20. M.M. Abdel-Mottaleb, B. Moulari, A. Béduneau, Y. Pellequer, and A. Lamprecht Nanoparticles enhance therapeutic outcome in inflamed skin therapy Eur. J. Pharm. Biopharm. 82 2012 151 157
21. A. Lamprecht, U. Schäfer, and C.-M. Lehr Size-dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa Pharm. Res. 18 2001 788 793 (Pubitemid 32783514)
22. H. Nakase, K. Okazaki, Y. Tabata, S. Uose, M. Ohana, K. Uchida, T. Nishi, A. Debreceni, T. Itoh, C. Kawanami, M. Iwano, Y. Ikada, and T. Chiba An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis J. Pharmacol. Exp. Ther. 297 2001 1122 1128 (Pubitemid 32472512)
23. A. Lamprecht, N. Ubrich, H. Yamamoto, U. Schäfer, H. Takeuchi, P. Maincent, Y. Kawashima, and C.-M. Lehr Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease J. Pharmacol. Exp. Ther. 299 2001 775 781
24. W. Zauner, N.A. Farrow, and A.M. Haines In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density J. Control. Release 71 2001 39 51 (Pubitemid 32195440)
25. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
26. S.K. Lai, Y.-Y. Wang, and J. Hanes Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues Adv. Drug Deliv. Rev. 61 2009 158 171
27. S.K. Lai, D.E. O'Hanlon, S. Harrold, S.T. Man, Y.Y. Wang, R. Cone, and J. Hanes Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus PNAS 104 2007 1482 1487 (Pubitemid 46214616)
28. F. Leonard, E.-M. Collnot, and C.-M. Lehr A three-dimensional co-culture of enterocytes, monocytes and dendritic cells to model the inflamed intestinal mucosa in vitro Mol. Pharm. 7 2010 2103 2119